Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Texas now offers first FDA-approved at-home cervical cancer test, boosting access in underserved areas.
Texans can now use the first FDA-approved at-home cervical cancer screening, developed by Teal Health, available in October 2025 as the eighth state to join the rollout.
The test, which uses a tampon-like device to collect a sample at home, detects high-risk HPV strains and is as accurate as in-office screenings.
It requires a telehealth visit for eligibility and results review, with the kit costing $99 and total costs around $249 for uninsured patients.
The program aims to improve access in rural and underserved areas, where screening rates remain low despite cervical cancer being preventable with early detection.
A national waitlist of about 40,000 people exists, with expansion to all states planned by 2026.
Texas ahora ofrece la primera prueba de cáncer cervical en el hogar aprobada por la FDA, lo que aumenta el acceso en áreas desatendidas.